T1	food 37 53	grapefruit juice
T2	drug 58 66	diazepam
T3	population 70 76	humans
T4	food 99 115	Grapefruit juice
T5	pharmacokinetics 158 173	bioavailability
T6	drug 177 186	triazolam
T7	drug 212 224	cyclosporine
T9	drug 288 298	felodipine
T10	drug 312 324	nitrendipine
T11	food 453 469	grapefruit juice
T12	food 576 592	grapefruit juice
T13	pharmacokinetics 596 617	plasma concentrations
T14	population 631 669	Eight healthy male and female subjects
T15	mode 698 702	Oral
T16	drug 710 718	diazepam
T17	dosage 748 754	250 ml
T18	food 755 760	water
T19	food 765 781	grapefruit juice
T20	pharmacokinetics 835 861	whole blood concentrations
T21	drug 865 873	diazepam
T22	pharmacokinetics 917 920	AUC
T23	drug 930 938	diazepam
T24	interaction 943 952	increased
T25	value 953 961	3.2-fold
T26	pharmacokinetics 978 982	Cmax
T27	interaction 987 996	increased
T28	value 997 1005	1.5-fold
T29	food 1024 1040	grapefruit juice
T30	food 1042 1058	Grapefruit juice
T31	interaction 1059 1068	postponed
T32	drug 1081 1089	diazepam
T33	value 1090 1111	from 1.50 h to 2.06 h
T34	drug 188 196	midazola
T35	drug 199 210	terfenadine
T36	drugClass 237 277	dihydropyridine calcium channel blockers
T8	drug 300 310	nifedipine
T37	drug 329 340	nisoldipine
T38	enzyme 393 426	cytochrome P450 isozyme (CYP) 3A4
T39	enzyme 511 517	CYP3A4
T40	interaction 432 449	inhibitory effect
A1	valence T40 Diminution
T41	drug 621 629	diazepam
T43	dosage 704 708	5 mg
T44	parameter 783 796	Blood samples
A2	valence T24 Augmentation
A3	valence T27 Augmentation
T45	pharmacokinetics 1073 1077	tmax
T42	interaction 17 28	Interaction
T46	interaction 146 153	improve
T47	interaction 497 507	inhibition
T48	pharmacokinetics 366 377	metabolized
R1	metabolism_decrease Arg1:T4 Arg2:T6	
R2	metabolism_decrease Arg1:T4 Arg2:T34	
R3	metabolism_decrease Arg1:T4 Arg2:T35	
R4	metabolism_decrease Arg1:T4 Arg2:T7	
R5	metabolism_decrease Arg1:T4 Arg2:T36	
R6	metabolism_decrease Arg1:T4 Arg2:T9	
R7	metabolism_decrease Arg1:T4 Arg2:T8	
R8	metabolism_decrease Arg1:T4 Arg2:T10	
R9	metabolism_decrease Arg1:T4 Arg2:T37	
R10	enzyme_inhibition Arg1:T29 Arg2:T23	
R11	metabolism_decrease Arg1:T30 Arg2:T32	
R12	increase_pharmacokinetic_parameter Arg1:T4 Arg2:T6	
R13	increase_pharmacokinetic_parameter Arg1:T4 Arg2:T34	
R14	increase_pharmacokinetic_parameter Arg1:T4 Arg2:T35	
R15	increase_pharmacokinetic_parameter Arg1:T4 Arg2:T7	
R16	increase_pharmacokinetic_parameter Arg1:T4 Arg2:T36	
R17	increase_pharmacokinetic_parameter Arg1:T4 Arg2:T9	
R18	increase_pharmacokinetic_parameter Arg1:T4 Arg2:T8	
R19	increase_pharmacokinetic_parameter Arg1:T4 Arg2:T10	
R20	increase_pharmacokinetic_parameter Arg1:T4 Arg2:T37	
R21	enzyme_inhibition Arg1:T11 Arg2:T37	
R22	enzyme_inhibition Arg1:T11 Arg2:T10	
R23	enzyme_inhibition Arg1:T11 Arg2:T8	
R24	enzyme_inhibition Arg1:T11 Arg2:T9	
R25	enzyme_inhibition Arg1:T11 Arg2:T36	
R26	enzyme_inhibition Arg1:T11 Arg2:T7	
R27	enzyme_inhibition Arg1:T11 Arg2:T35	
R28	enzyme_inhibition Arg1:T11 Arg2:T34	
R29	enzyme_inhibition Arg1:T11 Arg2:T6	
R30	increase_pharmacokinetic_parameter Arg1:T29 Arg2:T23	
R31	increase_pharmacokinetic_parameter Arg1:T30 Arg2:T32	
